The Axl tyrosine kinase receptor is associated with aggressive cancer and poor patient outcome in breast, liver and pancreatic cancer (Gjerdrum et al., 2010; Song et al., 2011; Reichl et al., 2015). The gene discussed is AXL; the disease is cancer.